Explore Bromantane dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
Bromantane is a small-molecule actoprotector (registered in Russia as Ladasten) studied for fatigue and stimulant-like research. It is a chemical compound, not a peptide, so the certificate of analysis (COA) is about chemical purity and accurate dose per unit.
Bromantane is a low-affinity dopamine reuptake inhibitor that also increases tyrosine hydroxylase expression and dopamine synthesis in the hypothalamus and ventral tegmental area. Russian pharmacology characterises it as a "mild psychostimulant with anxiolytic and immunomodulatory activity," distinguishing it editorially from classical amphetamines.[2]
A multicentre Russian Phase 3 trial in 728 patients with neurasthenia (asthenia) reported significant improvements in fatigue, anxiety, and sleep with 50–100 mg/day for 28 days versus placebo, and is the basis for the Russian registration.[3] Bromantane appears on the WADA Prohibited List (S6 stimulants) and was the substance behind several Russian Olympic doping disqualifications in 1996.[4]
Registered as a prescription anti-asthenic in the Russian Federation (Ladasten). **Not FDA-approved in the United States.** WADA-prohibited in-competition (S6 specified stimulants) — relevant for any athlete subject to anti-doping testing.
Bromantane has a reported half-life of ~11 hours. The pharmacokinetic reference models an interval of once daily (oral); this is not a measured community cadence or a dosing recommendation. A moderate half-life means once-daily dosing leaves some in your system between doses, building to a steady level over a few days. Pharmacokinetic source: Russian clinical pharmacology literature (Morozov; bromantane / Ladasten). It is catalogued under Other Peptides on WPA.
The WPA community has not yet logged enough Bromantane calculator sessions to publish dose, vial size, or bacteriostatic water distributions for it. This page therefore covers what is known about the compound itself; the usage charts fill in as researchers run the calculator.
These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.